The National Institutes of Health's National Heart, Lung, and Blood Institute (NHLBI) awarded $18.5 million to establish the Personalized NSAID Therapeutics Consortium (PENTACON), an international group of scientists led by Garret A. FitzGerald, MD, FRS, director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine, University of Pennsylvania. PENTACON...
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
↧